Lung Cancer Book Achieves #1 Best Seller Status on Amazon.com
12 6월 2013 - 11:00PM
OTC Markets
LUNG
CANCER BOOK ACHIEVES NUMBER 1 BEST
SELLER STATUS ON AMAZON.COM
STOCKTON,
CALIFORNIA/June 12, 2013 /
Newswire/ -- Viratech Corp. (OTC:VIRA) announced today that
Cancer.im?s 6th book of 235
books slated to be released on Amazon?s Kindle platform,
focusing
on Cancer, has achieved number 1 best-seller status for
Oncology.
The book, Find
& Stop Lung Cancer by Dr. Kevin Buckman and Cancer Patient
Advocate
Chris Ryan, has achieved number 1 best-seller status for Oncology.
The first
book, Find and Stop Breast Cancer, became a best seller
earlier this
year after only three days. The book Find
& Stop Lung Cancer can be bought here:http://www.amazon.com/Lung-Cancer-Find-Stop-ebook/dp/B00D7P6QTO/ref=sr_1_sc_1?s=books&ie=UTF8&qid=1370883742&sr=1-1-spell&keywords=lung+cancer+fid+and+stop
It is estimated that many have lung cancer right now
and do not know it. Unless it is big enough, there may be no
symptoms until
significant damage is done for there to be physical complaints.
Many health
authorities favor attempting to distinguish those who are likely to
develop
cancer, based on varying elements of risk, from those who are
not.
Smokers and
those exposed to carcinogens should be concerned about regular
check ups and
follow up chest x-rays. New lung cancer
markers are being evaluated, including breath tests for lung cancer
to help
find cancer early, when the prognosis is better.
Cancer can
be a slowly progressive
disease in some cases, and very rapid in
others.
Cancer is a
diverse class of diseases
which differ widely in their causes and biology. Any organism can
acquire
cancer. Nearly all known cancers arise gradually, as errors build
up in the
cancer cell, and its progeny and cancer cells can be found in our
bodies since
childhood and increase with age and exposure to
carcinogens.
According to the
book, ?Cancer.im
(www.cancer.im) is working to find new screening tests for cancer
and new modes
of therapy. The site, which launched on February 15, 2013, includes
a user
friendly Mission Adaptive Plan (a MAP) that can be tailored for
each user, and
15 modules for dealing with the disease, which are based on the
Robert Ryan
Cancer Protocol. Based on more than 19 medical studies on
quality of life
and associated longevity, following the Robert Ryan Cancer
Protocol
decreases the morbidity of cancer by increasing the quality of life
by the use
of these 15 steps which allows a cancer patient to be
proactive. There is
no charge for this service.? An explanatory video of the power of a
Cancer
Support Social Network can be seen here:
http://www.youtube.com/watch?v=dz1tHRb3wvU
About
Cancer.im
Through its
experience-based search
engine and technology, Cancer.im's goal is to become the primary
resource on
the web for people affected by cancer, for the purpose of making a
difference
in their own lives and the lives of others. Cancer.im?s
mission is to
empower every cancer patient with the ability to research their
disease and to
find, organize, and manage their own cancer support network at no
charge to
them. The goal of these support networks is to assist the patient
in conserving
needed energy by reducing the burden associated with their own
daily trials and
tribulations. Cancer.im will strive to convert this saved energy
into a higher
level of patient activity and a stronger determination to fight
their disease.
In
addition Cancer.im is seeking
new cancer researchers who wish to leverage its intellectual
property and
social network platform for the purpose of creating new
distribution and
engagement channels.
About
Viratech Corp.
Viratech Corp. has created the
first open source biotech research social network platform. The
purpose of the
platform is to make it possible for individuals or smaller
companies to compete
with larger companies in the race to patent new medicines or
technology. This
has been made possible by leveraging social collaboration in a way
that allows
new biotech ventures the ability to protect their intellectual
property, then
simultaneously allowing those same ventures the ability to promote
and
crowdsource their development.
Contact:
Kevin
Buckman MD
Viratech,
Corp.
http://viratech.org
Email Contact:
info@viratech.org
209-477-3030
Viratech (PK) (USOTC:VIRA)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Viratech (PK) (USOTC:VIRA)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
